Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07312188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a single - arm, multi - cohort, open - label, multi - center Phase II clinical study. It aims to evaluate the efficacy and safety of F182112 combined with different administration regimens in patients with relapsed or refractory multiple myeloma.
Trial Details
NCT Number NCT07312188
Lead Sponsor Shandong New Time Pharmaceutical Co., LTD
Conditions
(from sponsor)		 Relapsed or Refractory Multiple Myeloma
Related terms Multiple Myeloma, Recurrence
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov